Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	407.18	622.57	-122.75
Graham Fair Price	-70.01	0.20	0.68
PEG	4793.93	0.76	-0.02
Price/Book	-12.91	8.34	9.57
Price/Cash Flow	162.01	-216.17	82.50
Prices/Earnings	-817.42	-68.67	-7.48
Price/Sales	-34.38	11.24	17.13
Price/FCF	162.01	-216.17	82.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	258.22	0.16	-0.04
Operating Margin	96.76	-0.02	-0.54
ROA	90.91	< 0.005	-0.06
ROE	-0.32	-0.03	90.51
ROIC	-0.08	< 0.005	93.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.04	-2.98
Dividends QOQ	-0.21	0.09	-59.70
EBIT QOQ	-25.49	0.96	-96.24
EPS QOQ	-4.84	0.91	-81.25
FCF QOQ	0.38	-1.32	243.83
Revenue QOQ	-0.48	0.29	-38.80
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.33	42.43	-10.35
Days Sales Outstanding (DSO)	73.05	74.98	2.63
Inventory Turnover	1.90	2.12	11.55
Debt/Capitalization	0.76	0.76	-0.32
Quick Ratio	0.12	0.16	34.16
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.25	0.25	-2.66
Cash	0.02	0.03	69.47
Capex	-0.01	-0.01	-5.70
Free Cash Flow	0.03	< 0.005	-67.65
Revenue	0.14	0.18	29.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.20	0.24	15.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-30.47	167.49	449.76
Naive Interpretation	Member

06 - Financial Health · Bad

Rating